002172 澳洋健康
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)34.16371.964-28.627-204.613-38.840
总资产报酬率 ROA (%)1.8532.008-0.471-20.272-7.186
投入资产回报率 ROIC (%)2.6292.754-0.681-28.046-9.301

边际利润分析
销售毛利率 (%)13.71713.48513.9407.5170.501
营业利润率 (%)4.2163.7720.412-36.105-14.366
息税前利润/营业总收入 (%)5.3444.7313.166-31.024-9.517
净利润/营业总收入 (%)2.6392.312-0.778-35.234-15.283

收益指标分析
经营活动净收益/利润总额(%)88.58779.409-519.66629.931101.071
价值变动净收益/利润总额(%)-0.71029.6901,647.5440.369-10.124
营业外收支净额/利润总额(%)2.374-17.216963.344-1.386-1.068

偿债能力分析
流动比率 (X)0.6190.6450.7230.8040.609
速动比率 (X)0.5110.5550.6530.7570.552
资产负债率 (%)94.12596.66299.01098.67084.933
带息债务/全部投入资本 (%)86.28793.11293.65189.734--
股东权益/带息债务 (%)11.3056.3662.3312.82825.050
股东权益/负债合计 (%)7.2884.3331.6481.67417.447
利息保障倍数 (X)5.2093.1260.985-6.763-2.026

营运能力分析
应收账款周转天数 (天)54.16850.157135.98691.8390.000
存货周转天数 (天)37.81434.36735.20727.7350.000